LUCD - Latest News
Lucid Diagnostics Inc. (LUCD), operates in Healthcare / Medical - Devices, trades on NASDAQ.
Market capitalization stands near $189.1M. Beta to the broader market is 1.08.
The article list below shows the most recent LUCD headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent LUCD Headlines
Lucid Diagnostics Eyes Medicare Catalyst for EsoGuard Growth
marketbeat.com - Aug 15, 2026
Lucid Diagnostics NASDAQ: LUCD is positioning its EsoGuard test as a non-invasive tool to identify Barrett's Esophagus, a precancerous condition assoc
PAVmed Provides Business Update and Reports Second Quarter 2026 Financial Results
prnewswire.com - Aug 14, 2026
Veris Health accelerated its commercial engagement with OSU-The James Veris Health implantable physiological monitor achieved development milestones t
Lucid Diagnostics Inc. (LUCD) Q2 2026 Earnings Call Transcript
seekingalpha.com - Aug 13, 2026
Lucid Diagnostics Inc.
Lucid Diagnostics Q2 Earnings Call Highlights
marketbeat.com - Aug 13, 2026
Lucid Diagnostics NASDAQ: LUCD reported second-quarter revenue of $1. 5 million on 2,770 EsoGuard tests, as the company continued to target quarterly
Lucid Diagnostics Inc. (LUCD) Reports Q2 Loss, Lags Revenue Estimates
zacks.com - Aug 13, 2026
Lucid Diagnostics Inc. (LUCD) came out with a quarterly loss of $0.
How News Affects LUCD Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track LUCD's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked LUCD news questions
- What is the latest LUCD news headline?
- The most recent LUCD headline (Aug 15, 2026) is "Lucid Diagnostics Eyes Medicare Catalyst for EsoGuard Growth". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the LUCD news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What LUCD news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual LUCD options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.